These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30488623)

  • 1. Editorial: direct anti-viral agents, hepatitis C virus eradication, and gut-liver axis-another mechanistic piece to the puzzle.
    Tariq R; Wahab A; Singal AK
    Aliment Pharmacol Ther; 2018 Dec; 48(11-12):1321-1322. PubMed ID: 30488623
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness and safety of direct-acting antiviral agents for treatment of patients with chronic hepatitis C virus infection].
    Yang J; Rao HY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Mar; 26(3):175-178. PubMed ID: 29804389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: ribavirin continues to play a role in treatment with direct-acting antivirals for hepatitis C virus-infected patients with decompensated cirrhosis.
    Waldenström J; Lagging M
    Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1115-1116. PubMed ID: 29105131
    [No Abstract]   [Full Text] [Related]  

  • 4. Viral eradication reduces both liver stiffness and steatosis in patients with chronic hepatitis C virus infection who received direct-acting anti-viral therapy.
    Tada T; Kumada T; Toyoda H; Sone Y; Takeshima K; Ogawa S; Goto T; Wakahata A; Nakashima M; Nakamuta M; Tanaka J
    Aliment Pharmacol Ther; 2018 Apr; 47(7):1012-1022. PubMed ID: 29424449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter: the role of direct-acting anti-virals in determining the risk of hepatocellular carcinoma development in patients with hepatitis C virus-induced cirrhosis.
    Kao WY; Su CW
    Aliment Pharmacol Ther; 2018 Apr; 47(8):1230-1231. PubMed ID: 29574869
    [No Abstract]   [Full Text] [Related]  

  • 6. New Direct-Acting Antiviral Agents Can Be Hepatotoxic in Patients With Hepatitis C Virus Infection and Decompensated Cirrhosis.
    Ou P; Li F; Chen J
    Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1669-1671. PubMed ID: 27329403
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiviral treatment for cirrhosis due to hepatitis C: a review.
    Somasundaram A; Venkataraman J
    Singapore Med J; 2012 Apr; 53(4):231-5. PubMed ID: 22511042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current Guidelines for treatment of hepatitis C. The eradication of HCV as a goal].
    Sarrazin C; Zeuzem S
    Pharm Unserer Zeit; 2011 Jan; 40(1):52-9. PubMed ID: 21194083
    [No Abstract]   [Full Text] [Related]  

  • 9. Toward chronic hepatitis C eradication in HIV-positive patients, including those cirrhotic and infected with genotype 3 viruses.
    Menard A; Aherfi S; Mokhtari S; Dhiver C; Ravaux I; Tissot-Dupont H; Meddeb L; Brouqui P; Stein A; Colson P
    Gut; 2017 Oct; 66(10):1868-1869. PubMed ID: 28073889
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to: "High mortality during direct acting antiviral therapy for hepatitis C patients with Child's C cirrhosis: Results of the Irish Early Access Programme".
    Foster GR
    J Hepatol; 2016 Aug; 65(2):448. PubMed ID: 27132169
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis C Virus Eradication with New Interferon-Free Treatment Improves Metabolic Profile in Hepatitis C Virus-Related Liver Transplant Recipients.
    Beig J; Orr D; Harrison B; Gane E
    Liver Transpl; 2018 Aug; 24(8):1031-1039. PubMed ID: 29577581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study.
    Ferrarese A; Germani G; Gambato M; Russo FP; Senzolo M; Zanetto A; Shalaby S; Cillo U; Zanus G; Angeli P; Burra P
    World J Gastroenterol; 2018 Oct; 24(38):4403-4411. PubMed ID: 30344424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Gastroenterological Association Institute Clinical Practice Update-Expert Review: Care of Patients Who Have Achieved a Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C Infection.
    Jacobson IM; Lim JK; Fried MW
    Gastroenterology; 2017 May; 152(6):1578-1587. PubMed ID: 28344022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver Fibrosis and Body Mass Index Predict Hepatocarcinogenesis following Eradication of Hepatitis C Virus RNA by Direct-Acting Antivirals.
    Akuta N; Kobayashi M; Suzuki F; Sezaki H; Fujiyama S; Kawamura Y; Hosaka T; Kobayashi M; Saitoh S; Suzuki Y; Arase Y; Ikeda K; Kumada H
    Oncology; 2016; 91(6):341-347. PubMed ID: 27694754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiviral treatment of hepatitis C virus infection].
    Silvain C
    Rev Med Interne; 1999 Aug; 20 Suppl 3():331s-340s. PubMed ID: 10480183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of pretransplant and posttransplant viral cirrhosis].
    Suárez FJ; Otero A; Gómez M; Souto J; Vázquez-Iglesias JL
    Gastroenterol Hepatol; 2001 Feb; 24 Suppl 1():58-63. PubMed ID: 11279895
    [No Abstract]   [Full Text] [Related]  

  • 17. Clearance of Hepatitis C Virus After Fixed-Dose Combination Ledipasvir/Sofosbuvir in an Adolescent Female With Decompensated Cirrhosis.
    Smith SK; Rosenthal P
    J Pediatr Gastroenterol Nutr; 2016 Nov; 63(5):516-517. PubMed ID: 27243422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of antiviral therapy in Egyptian Hepatitis C Virus (HCV) genotype 4 patients with advanced liver fibrosis.
    el-Khattib AA; Abdelhakam SM; Ghoraba DM; Ibrahim WA; Sayed MM
    Eur J Intern Med; 2012 Jan; 23(1):e34-5. PubMed ID: 22153547
    [No Abstract]   [Full Text] [Related]  

  • 19. Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls.
    Heidrich B; Vital M; Plumeier I; Döscher N; Kahl S; Kirschner J; Ziegert S; Solbach P; Lenzen H; Potthoff A; Manns MP; Wedemeyer H; Pieper DH
    Liver Int; 2018 Jan; 38(1):50-58. PubMed ID: 28561276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: hepatitis C direct acting anti-viral agents and the kidney.
    Hussaini T; Yoshida EM
    Aliment Pharmacol Ther; 2017 Aug; 46(3):378-379. PubMed ID: 28677286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.